Sykes Annemarie, Mallia Patrick, Johnston Sebastian L
Department of Respiratory Medicine, National Heart and Lung Institute and Wright Fleming Institute Infection and Immunity, Imperial College London, Norfolk Place, London, W2 1PG, UK.
Proc Am Thorac Soc. 2007 Dec;4(8):642-6. doi: 10.1513/pats.200707-101TH.
Chronic obstructive pulmonary disease (COPD) is increasing in prevalence. Acute exacerbations of COPD are the major cause worldwide of morbidity, mortality, and health care costs as well as decreased quality of life for the individual. The majority of exacerbations are infectious in etiology. Bacteria are detected in 50% of exacerbations and polymerase chain reaction techniques have established that, in half to two-thirds of exacerbations, viruses are causative pathogens. Combined bacterial and viral infection can be identified in 25% of exacerbations and these dual infections are often more severe. Despite occurring frequently, the mechanisms by which infection with these pathogens causes exacerbations are incompletely understood. This highlights the need for continued research, because a greater understanding of the mechanism of COPD exacerbations may lead to identification of potential targets for the development of therapeutic options for this increasingly common condition.
慢性阻塞性肺疾病(COPD)的患病率正在上升。COPD急性加重是全球范围内发病、死亡、医疗保健费用以及个体生活质量下降的主要原因。大多数加重的病因是感染。在50%的加重病例中检测到细菌,聚合酶链反应技术已证实,在一半至三分之二的加重病例中,病毒是致病病原体。在25%的加重病例中可识别出细菌和病毒合并感染,且这些双重感染往往更为严重。尽管频繁发生,但这些病原体感染导致加重的机制尚未完全了解。这凸显了持续研究的必要性,因为对COPD加重机制的更深入理解可能会为这种日益常见的疾病开发治疗方案找到潜在靶点。